12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Mylan sales and marketing update

Mylan launched a generic version of hypertension drug Diovan HCT from Novartis AG (NYSE:NVS; SIX:NOVN,...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >